Document Type

Article

Publication Date

5-19-2022

Publication Title

Nat Commun

Keywords

Animals, Electron Transport Complex I, Glutamine, Mice, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Receptor, Notch1, T-Lymphocytes

JAX Source

Nat Commun 2022 May 19; 13(1):3801

Volume

13

Issue

1

First Page

2801

Last Page

2801

ISSN

2041-1723

PMID

35589701

DOI

https://doi.org/10.1038/s41467-022-30396-3

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is commonly driven by activating mutations in NOTCH1 that facilitate glutamine oxidation. Here we identify oxidative phosphorylation (OxPhos) as a critical pathway for leukemia cell survival and demonstrate a direct relationship between NOTCH1, elevated OxPhos gene expression, and acquired chemoresistance in pre-leukemic and leukemic models. Disrupting OxPhos with IACS-010759, an inhibitor of mitochondrial complex I, causes potent growth inhibition through induction of metabolic shut-down and redox imbalance in NOTCH1-mutated and less so in NOTCH1-wt T-ALL cells. Mechanistically, inhibition of OxPhos induces a metabolic reprogramming into glutaminolysis. We show that pharmacological blockade of OxPhos combined with inducible knock-down of glutaminase, the key glutamine enzyme, confers synthetic lethality in mice harboring NOTCH1-mutated T-ALL. We leverage on this synthetic lethal interaction to demonstrate that IACS-010759 in combination with chemotherapy containing L-asparaginase, an enzyme that uncovers the glutamine dependency of leukemic cells, causes reduced glutaminolysis and profound tumor reduction in pre-clinical models of human T-ALL. In summary, this metabolic dependency of T-ALL on OxPhos provides a rational therapeutic target.

Comments

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.

Download

Share

COinS